BioMatrix Specialty Pharmacy, a nationwide specialty pharmacy provider, announced yesterday that it has named Nick Karalis as its new chief executive officer.
Presently, Karalis serves as BioMatrix chief operating officer and will also serve on the firm's board of directors.
Karalis is a graduate of University of the Sciences and has more than 25 years of executive leadership experience as a pharmacist and pharmacy owner/operator. He was a founding principal and CEO of Elwyn Pharmacy Group, which became part of BioMatrix in 2017. He was also a co-founder and president at Community Specialty Pharmacy Network. His prior experience includes various pharmacy companies that he founded and operated. He is a member of Cardinal Health's National Advisory Board and on the Leadership Counsel for the American Red Cross. He is a founding board member of Hellenic Hearts, an editorial board member of Specialty Pharmacy Times and the winner of the 2014 Smart/CEO Circle of Excellence award.
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers